步长制药：全资子公司拟750万元受让6个保健食品技术

Core Viewpoint - The company, Buchang Pharma, announced that its wholly-owned subsidiary, Shandong Danhong, plans to transfer technology related to six health food products, including Yunting brand Ejiao Dihuang oral liquid, to the Shaanxi Functional Food Engineering Center for a price of 7.5 million yuan [1] Group 1: Business Expansion - The technology transfer is expected to help expand the company's business and enrich its product line [1] - The transaction has been approved by the 39th meeting of the fifth board of directors and does not constitute a related party transaction or a major asset restructuring [1] Group 2: Financial Performance - Shandong Danhong reported a revenue of 1.331 billion yuan and a net profit of 226 million yuan for the year 2024 [1] - For the period from January to September 2025, the company achieved a revenue of 1.402 billion yuan and a net profit of 334 million yuan [1] Group 3: Uncertainty - There is uncertainty regarding the completion of the technology transfer [1]